UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934 (Amendment No. 2)*

BioLineRx Ltd.

(Name of Issuer)

Ordinary Shares, par value NIS \$0.01 per share

(Title of Class of Securities)

09071M106

(CUSIP Number)

December 31, 2016

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is fled:

[_] Rule 13d-1(b)

[X] Rule 13d-1(c)

[_] Rule 13d-1(d)

The remainder of this cover page shall be flled out for a reporting person's initial fling on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "fled" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No 09071M106

__________

NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Broadfn Capital, LLC

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

fle:///C|/Users/normank/Documents/SEC%20flings%202017/Q1/Broadfn%2013G.htm[2/14/2017 6:29:05 AM]

3. SEC USE ONLY

4. CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

1. SOLE VOTING POWER
2. 0
1. SHARED VOTING POWER
2. 0
1. SOLE DISPOSITIVE POWER
2. 0
1. SHARED DISPOSITIVE POWER
2. 0

9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

0
1. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

[_]

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

0.00%

1. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
2. OO, IA

CUSIP No 09071M106

NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Broadfn Healthcare Master Fund, Ltd.

2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a) [_] (b) [X]

SEC USE ONLY

4.	CITIZENSHIP OR PLACE OF ORGANIZATION
	Cayman Islands
	NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.	SOLE VOTING POWER
	0
6.	SHARED VOTING POWER
	0
7.	SOLE DISPOSITIVE POWER
	0
8.	SHARED DISPOSITIVE POWER
	0
9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	0
10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE
	INSTRUCTIONS)	[_]
11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	0.00%
12.	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	CO



CUSIP No	09071M106

1.	NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	Kevin Kotler
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
		(a) [_] (b) [X]
3.	SEC USE ONLY
4.	CITIZENSHIP OR PLACE OF ORGANIZATION

United States of America

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

5.		SOLE VOTING POWER
	0
6.		SHARED VOTING POWER
	0
7.		SOLE DISPOSITIVE POWER
	0
8.	SHARED DISPOSITIVE POWER
	0
9.		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	0
10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE
		INSTRUCTIONS)	[_]
11.		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	0.00%
12.		TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	IN, HC

CUSIP No	09071M106
Item 1.	(a).	Name of Issuer:
		BioLineRx Ltd.

	(b).	Address of Issuer's Principal Executive Offces:
		2 HaMa'ayan Street Modi'in Technology Park
		Modi'in L3 7177871, Israel
Item 2.	(a).	Name of Person Filing:
		Broadfn Capital, LLC
		Broadfn Healthcare Master Fund, Ltd. Kevin Kotler
	(b).	Address of Principal Business Offce, or if None, Residence:
		Broadfn Capital, LLC

			300 Park Avenue, 25 th Floor New York, New York 10022 United States of America
			Broadfn Healthcare Master Fund, Ltd. 20 Genesis Close Ansbacher House, Second Floor P.O. Box 1344 Grand Cayman KY1-1108 Cayman Islands
			Kevin Kotler c/o Broadfn Capital, LLC 300 Park Avenue, 25 th Floor New York, New York 10022 United States of America
	(c)		Citizenship:
		Broadfn Capital, LLC – Delaware Broadfn Healthcare Master Fund, Ltd. – Cayman Islands Kevin Kotler – United States of America
	(d).		Title of Class of Securities:
			Ordinary Shares, par value NIS \$0.01 per share
	(e).		CUSIP Number:
			09071M106
Item 3.		This Statement is fled pursuant to ss.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person fling is a
	(a)	[_]	Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78c).
	(b)	[_]	Bank as defned in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c).
	(c)	[_]	Insurance company as defned in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c).
	(d)	[_]	Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
	(e)	[_]	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
	(f)	[_]	An employee beneft plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
	(g)	[_]	A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
	(h)	[_]	A savings association as defned in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);
	(i)	[_]	A church plan that is excluded from the defnition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
	(j)	[_]	Group, in accordance with s.240.13d-1(b)(1)(ii)(J).

Item 4. Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identifed in Item 1.

(a) Amount benefcially owned: